AB0049 Human Type 1 Innate Lymphoid Cells Accumulate in the Inflamed Synovium in Spondyloarthritis

Abstract

BackgroundSpondyloarthritis (SpA) is a major form of chronic inflammatory arthritis characterized by inflammation of axial and peripheral joints and by pathologic new bone formation leading to ankylosis. Consistent genetic, experimental, and clinical evidence indicates that IL-23/IL-17 immune axis plays a pivotal role in the pathophysiology SpA. It remains, however, unknown which IL-23 responsive cells are the major cellular source of IL-17 in SpA. Innate lymphoid cells (ILCs) are an emerging family of innate immune cells that produce various cytokines, including IL-17 and IL-22, and play critical roles in regulation of inflammation and tissue remodeling.ObjectivesIn this study we investigated the presence and phenotype of ILCs in the peripheral blood and inflamed peripheral joints of patients with SpA.MethodsPaired peripheral blood (PB), synovial fluid (SF) and synovial tissue (ST) were obtained from SpA patients with actively inflamed knee joints. ILCs (lineage negative, CD45+CD127+ CD161+) were analysed by flow cytometry.ResultsILCs were present in all three compartments of patients with SpA. Analysis of ST revealed a significantly increased frequency of total ILCs in the joint compared with PB ((median (IQR) 0.37 (0.12-1.12)% of the lymphocyte population in ST versus 0.06 (0.04-0.09) % in PB, p=0.016). Immunophenotyping of ILC subsets showed a statistically significant increase in the frequency of ILC1 (CRTH2-NKp44-ckit-) in ST (37.8%; 74.43-20.47%) versus SF (7.27%; 0.6-25.1%, p=0.008) and PB (3.45%; 1.45-9.25%, p=0.004). The second most prominent ILCs in the joint were NCR-negative ILC3 (CRTH2-NKp44-ckit+), composing 33.45% (9.54-50.64%) of the total ILCs. NCR-positive ILC3 (CRTH2-NKp44+ckit+) and ILC2 (CRTH2+) populations were present in synovium at lower frequencies.ConclusionsWe observed an absolute and relative enrichment of both ILC1 and NCR-negative ILC3 in the inflamed ST of patient with spondyloarthritis as compared to PB and SF. As studies in other tissues such as gut and tonsil revealed that these IL-23 responsive ILC subsets can be an important source of IL-17 and /or IL-22 (1, 2), we will further investigate the cytokine production by these synovial ILCs.ReferencesGeremia et al. J Exp Med. 2011 208(6):1127-1133Bernink et al. Nature Immunology 14(3):221-229Disclosure of InterestNone declared

ILCs, the Frontliners of Immune Defense in Mouse Model of Colorectal Cancer

“…similar to our ndings, higher frequency of ILC1 have been documented in bronchial samples and peripheral blood from patients with chronic obstructive pulmonary disease (COPD), CD (Crohn's disease), synovial uid, and tissue samples from patients with in ammatory arthritis and those with RA in peripheral blood samples of patients with acute-phase anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). [12][13][14][15][16].…”

Innate Lymphocytes in Inflammatory Arthritis

“…ILC1 populations were present in the SF and synovial tissue in inflamed RA, PsA and SpA patients (134). The frequency of ILC1s in the SF and synovial tissue was significantly increased compared with that of PBMCs from SpA patients (135). ILC1 frequency was significantly increased in RA or in individuals at risk of RA compared with that of controls, indicating a potential role of ILC1s in RA pathogenesis (136).…”

Helper-like Innate Lymphoid Cells in Humans and Mice

“…The major cytokine produced by ILC1s is IFN-γ, which has been implicated in many inflammatory diseases and can be targeted clinically (Table 1). Relative to healthy individuals, ILC1 numbers can be increased in bronchial samples and peripheral blood from patients with chronic obstructive pulmonary disease (COPD) [58], inflamed intestinal samples from patients with CD [13], synovial fluid and tissues from patients with inflammatory arthritis and those with RA [67,68], joints of patients with spondyloarthritis [69], as well as in the peripheral blood of patients with acute-phase anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) [70], systemic sclerosis (SSc) [71], or systemic lupus erythematous (SLE) [72]. Individuals at risk of developing RA also a Inhibits production of IL-13 by ILC2s and enhances ability of NK cells to induce apoptosis of eosinophils in humans.…”